How Did Moderna's COVID Vaccine Results in Teens Stack Up Against Pfizer's?

Pfizer's (NYSE: PFE) COVID-19 vaccine is already available to teens. Moderna's (NASDAQ: MRNA) might not be too far behind. The company recently announced positive results from a clinical study of its vaccine in children between the ages of 12 and 18. In this Motley Fool Live video recorded on May 26, Motley Fool contributors Keith Speights and Brian Orelli discuss how Moderna's results stack up against Pfizer's.

Continue reading

Source Fool.com